Company: BLUWU
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001641172-25-012302
Chunk: 18

Company: Blue Water Acquisition Corp. III
Filing Date: 2025-05-23
Form: S-1/A
Chunk 18
---
 recognized career in the healthcare industry over the past 25 years spanning business, academic innovation and as an entrepreneur. Dr. Hawkins is a former director of the U.S. Department of Energy’s Human Genome Project and has diverse commercial and managerial experience at leading global companies. Dr. Hawkins currently serves on several boards in the life science industry. In April 2024, Dr. Hawkins was appointed to the Supervisory Board of Genomtec S.A., a public molecular diagnostics company based in Poland. He has been a member of the Board of Directors of Resistell AG, a medical technology company, since December 2023, and is also a member of the Science Advisory Boards of Noscendo GmbH and lifespin GmbH. Since January 2016, Dr. Hawkins has served as an Operating Advisor to GreyBird Ventures LLC, a venture capital firm focused on medical diagnostic solutions. Previously, Dr. Hawkins has held several senior executive roles at HP, GE, Siemens Healthcare and Philips. He was also a successful entrepreneur building and selling a diagnostic company based in Shanghai & San Francisco. Dr. Hawkins obtained a B.Sc. at the University of Sussex in the United Kingdom and completed a Ph.D. in Biochemistry from the Laboratory of Molecular Biology, Cambridge in 1993.

I sh S. Dugalwill serve as a member of our board of directors upon the effectiveness of the registration statement of which this prospectus forms a part. Mr. Dugal has 20 years of venture capital and private equity investment experience with a focus on artificial intelligence (“AI”), software, and deep tech. He is the co-founder and a Managing Partner at IronArc Ventures, a venture capital firm based in Silicon Valley, and serves as the CIO of GoldenArc, a private investment firm. Mr. Dugal has led investments in companies like Anthropic, Scale AI, Groq, Digital Ocean (NYSE: DOCN), Rubrik (NYSE: RBRK), Robinhood (Nasdaq: HOOD), and many others. Previously, Mr. Dugal was an Investment Director at a large European asset management firm. Earlier, he was an Associate at Paladin Capital Group, a multi-stage PE/VC firm. Mr. Dugal holds an MBA from The Wharton School – University of Pennsylvania and a B.S. with High Honors from the University of Maryland, College Park.

Laurent D. Hermouetwill serve as a member of our board of directors upon the effectiveness of the registration statement of which this prospectus forms a part. Mr.